You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恩華藥業(002262.SZ)自2019年12月起不再將恩華和潤納入合併報表範圍
格隆匯 12-12 15:53

格隆匯12月12日丨恩華藥業(002262.SZ)公佈,2019年11月29日,公司第五屆董事會第六次會議審議通過了《關於轉讓控股子公司恩華和潤部分股權的議案》,同意公司將所持有控股子公司江蘇恩華和潤醫藥有限公司(“恩華和潤”)的56%股權作價人民幣5779.2萬元轉讓給南京醫藥股份有限公司。此次股權轉讓後,公司持有恩華和潤的股權比例下降至24%。

2019年12月11日,恩華和潤在徐州市市場監督管理局完成股東、法定代表人的變更登記手續,並將新的恩華和潤《公司章程》、董事、監事、經理進行備案,同時換領了新的營業執照。

此次恩華和潤工商變更登記及備案手續完成後,公司自2019年12月起不再將恩華和潤納入合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account